<DOC>
	<DOCNO>NCT00856843</DOCNO>
	<brief_summary>To evaluate safety efficacy BLI800 v FDA approve bowel preparation colonoscopic examination adult subject .</brief_summary>
	<brief_title>BLI800-303 : An Efficacy Evaluation 2 Different Bowel Cleansing Preparations Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>1 . Male female outpatient undergo colonoscopy routinely accept indication . 2 . At least 18 year age 3 . Otherwise good health , determine physical exam medical history 4 . If female , childbearing potential , use acceptable form birth control 5 . Negative urine pregnancy test screening , applicable 6 . In Investigator 's judgment , subject mentally competent provide inform consent participate study 1 . Subjects know suspected ileus , severe ulcerative colitis , gastrointestinal obstruction , gastric retention , bowel perforation , toxic colitis megacolon . 2 . Subjects previous gastrointestinal surgery . 3 . Subjects know suspected electrolyte abnormality hypernatremia , hyponatremia , hyperphosphatemia , hypokalemia , hypocalcemia , dehydration , secondary use diuretic angiotensin convert enzyme ( ACE ) inhibitor . 4 . Subjects clinically significant electrolyte abnormality base Visit 1 laboratory result . 5 . Subjects impaired consciousness predisposes pulmonary aspiration . 6 . Subjects undergo colonoscopy foreign body removal decompression . 7 . Subjects pregnant lactating , intend become pregnant study . 8 . Subjects childbearing potential refuse pregnancy test . 9 . Subjects allergic preparation component 10 . Subjects , opinion Investigator , include study reason , include inability follow study procedure . 11 . Subjects participate investigational surgical , drug , device study within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>colonoscopy</keyword>
	<keyword>bowel preparation</keyword>
</DOC>